Work

Target-specific therapy for actionable and approved tumor-agnostic biomarkers: Influence on survival in rare cancers.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3123

Authors: Razelle Kurzrock, Stamatina Fragkogianni, Rosa Hernansaiz-Ballesteros, Chenyang Li, Ying Hong, Binyam Yilma, Brandon Price, Emma Tung Corcoran, Catherine Igartua, Justin Guinney, Ezra E.W. Cohen

Institutions: Medical College of Wisconsin, Tempus Labs (United States)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162533232

Cites:

Cited by:

Related to: